SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN ... SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, TWO SHEETS ARE DEFINED.
Mass: 18.015 Da / Num. of mol.: 288 / Source method: isolated from a natural source / Formula: H2O
Compound details
ENGINEERED MUTATION IN CHAIN A, SER 178 TO ASN ENGINEERED MUTATION IN CHAIN A, ASN 226 TO ASP ...ENGINEERED MUTATION IN CHAIN A, SER 178 TO ASN ENGINEERED MUTATION IN CHAIN A, ASN 226 TO ASP ENGINEERED MUTATION IN CHAIN A, ASN 441 TO GLN
Has protein modification
Y
Sequence details
SEQUENCE EXPRESSED COMPRISES RESIDUES 1 TO 445. MUTATIONS S136N, N184D AND N399Q HAVE BEEN ...SEQUENCE EXPRESSED COMPRISES RESIDUES 1 TO 445. MUTATIONS S136N, N184D AND N399Q HAVE BEEN INTRODUCED TO ELIMINATE POTENTIAL N-GLYCOSYLATION SITE.
-
Experimental details
-
Experiment
Experiment
Method: X-RAY DIFFRACTION / Number of used crystals: 1
-
Sample preparation
Crystal
Density Matthews: 2 Å3/Da / Density % sol: 38 %
Crystal grow
pH: 6.5 Details: THE CRYSTALLISATION MIXTURE CONSISTED OF 10-12% (W/V) PEG3350, 100-200MM IMIDAZOLE, PH 7.0, 5-10% (V/V) ISOPROPANOL, AND 1% (V/V) DMF OR 3% (V/V) T-BUTANOL. THE PROTEIN SOLUTION WAS DILUTED ...Details: THE CRYSTALLISATION MIXTURE CONSISTED OF 10-12% (W/V) PEG3350, 100-200MM IMIDAZOLE, PH 7.0, 5-10% (V/V) ISOPROPANOL, AND 1% (V/V) DMF OR 3% (V/V) T-BUTANOL. THE PROTEIN SOLUTION WAS DILUTED BY 40 - 60% WITH THE CRYSTALLISATION BUFFER, GIVING A FINAL CONCENTRATION OF 4-6 MG. ML-1 IN SUSPENDED DROPS OF VOLUME 2 - 3 PERCENT.